|
R&D Systems
biotinylated anti cxcl12α mab ![]() Biotinylated Anti Cxcl12α Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF310/Human%2FMouse+CXCL12%2FSDF-1+Biotinylated+Antibody/pmc01887733-72-5-9 Average 93 stars, based on 1 article reviews
biotinylated anti cxcl12α mab - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
R&D Systems
sdf1 ![]() Sdf1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF310/Human%2FMouse+CXCL12%2FSDF-1+Biotinylated+Antibody/10__1158_slash_0008___5472__can___07___2181-70-21-25 Average 92 stars, based on 1 article reviews
sdf1 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Balzer GmbH
freeze-fracture unit baf310 ![]() Freeze Fracture Unit Baf310, supplied by Balzer GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/BAF310/freeze+fracture+unit+baf310/pm15661001-198-18-21 Average 90 stars, based on 1 article reviews
freeze-fracture unit baf310 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: The Journal of Experimental Medicine
Article Title: Inflammation Controls B Lymphopoiesis by Regulating Chemokine CXCL12 Expression
doi: 10.1084/jem.20031104
Figure Lengend Snippet: Adjuvants and TNFα suppress BM CXCL12. (A) Adjuvants and TNFα reduce BM CXCL12 protein, but do not alter total protein levels. Bars represent mean ± SD protein concentrations. (B) CXCL12 protein levels in BM plasma of BL/6 mice after immunization. Points represent mean ± SD CXCL12 concentrations. Asterisks indicate significant differences from controls: *, P < 0.05; **, P < 0.01. (C) Adjuvant-induced suppression of BM CXCL12 is mitigated in TNFα −/− mice. 3 d after immunization, CXCL12 protein concentrations in BM plasma of TNFα −/− and control mice were determined. Experimental groups are as follows: naive TNF +/+ , untreated B6.129SF2; NP-CGG/IFA TNF +/+ , immunized B6.129SF2; naive TNF −/− , untreated TNFα 2/− ; and NP-CGG/IFA TNF −/− , immunized TNF −/− .
Article Snippet: Bound CXCL12 was detected by
Techniques: Clinical Proteomics, Adjuvant, Control
Journal: Cancer Research
Article Title: Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial Cells
doi: 10.1158/0008-5472.can-07-2181
Figure Lengend Snippet: Figure 1. Effects of Dll4 overexpression on endothelial cell migration and attachment. A, effects of Dll4 expression, anti-VEGF, or anti-CXCR4 neutralization on HUVEC cord formation. HUVECs (40 103 parental or retrovirus-transduced cells) were incubated for 18 h on Matrigel-coated wells. Anti-VEGF and anti-CXCR4 neutralizing antibodies were added to control HUVEC at a concentration of 10 Ag/mL. Representative images. B, SDF1 (100 ng/mL)-induced Transwell migration of control and Dll4-overexpressing HUVECs (5 105 per well) over 16 to 20 h of incubation. Columns, mean fold increase in cell migration compared with medium alone in four independent experiments; bars, SE. *, P = 0.007. C, representative images reflecting attachment to wells precoated with laminin (5 Amol/L) or SDF1 (2–4 Ag/mL) by control and Dll4-overexpressing HUVECs (2.5 104 to 5 104 per well). Cells were incubated for 1 h at 37jC, washed with PBS, fixed with 4% paraformaldehyde, and stained with crystal violet. Phase-contrast microscopy. Original magnification, 4. D, quantitative analysis of attachment in control and Dll4-overexpressing HUVECs. Attachment was quantified by measuring pixels stained for crystal violet using ImageJ, and percent attachment was calculated by dividing the attachment of control HUVEC to 0.1% gelatin. Columns, mean of eight independent experiments; bars, SE. *, P = 0.02.
Article Snippet: After transfer, Immobilon-P membranes (Millipore) were incubated overnight with antibodies against the following proteins: CD184 (2B11, 1:250), RDC1 (12870, 1:250; Abcam),
Techniques: Over Expression, Migration, Expressing, Neutralization, Incubation, Control, Concentration Assay, Staining, Microscopy
Journal: Cancer Research
Article Title: Regulation of CXCR4 by the Notch Ligand Delta-like 4 in Endothelial Cells
doi: 10.1158/0008-5472.can-07-2181
Figure Lengend Snippet: Figure 3. Regulation of CXCR4 expression by extracellular rhDLL4 and requirement of Notch signaling. A, COOH-terminal Notch1 fragment detected by immunoblotting with specific antibodies. The membrane was reblotted for h-actin. Cell lysates were prepared from semiconfluent cultures of HUVEC (parental and infected with control retrovirus or Dll4 retrovirus). B, quantitative RT-PCR analysis of relative GAPDH and CXCR4 mRNA expression in HUVECs stimulated with BSA or extracellular rhDLL4 at 48 h (left) or at 4, 8, 16, 18, 20, 24, 48, and 72 h (right). The results represent the mean of four independent determinations (left; *, P = 0.015) or two to four determinations per time point (right). Bars, SE. C, CXCR4, SDF1, RDC1, and VEGF expression in HUVECs stimulated for 72 h with BSA or extracellular rhDLL4 evaluated by immunoblotting with specific antibodies. Membranes were reblotted with goat anti–h-actin antibody. Representative of two to three independent determinations. D, COOH-terminal Notch1 fragment detected by immunoblotting of cell lysates from semiconfluent cultures of HUVEC transduced with Dll4 or control retrovirus after 72 h of incubation with L-685,458 (GSI) or diluent (DMSO) only. Left, the membrane was reblotted for h-actin; right, quantitative RT-PCR analysis of relative GAPDH and CXCR4 mRNA expression in DMSO or L-685,458 inhibitor-treated (72 h) HUVECs stimulated with BSA or extracellular rhDLL4. Columns, mean of three independent determinations; bars, SE. *, P = 0.003.
Article Snippet: After transfer, Immobilon-P membranes (Millipore) were incubated overnight with antibodies against the following proteins: CD184 (2B11, 1:250), RDC1 (12870, 1:250; Abcam),
Techniques: Expressing, Western Blot, Membrane, Infection, Control, Quantitative RT-PCR, Transduction, Incubation